Serological assessment of gastric mucosal atrophy in gastric cancer.
about
Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infectionGeneration of monoclonal antibody MS17-57 targeting secreted alkaline phosphatase ectopically expressed on the surface of gastrointestinal cancer cellsGastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia.The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical researchVirulence genes of Helicobacter pylori in the Dominican Republic.Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancerPrevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar.The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth ChinaShort term micronutrient-antioxidant supplementation has no impact on a serological marker of gastric atrophy in Zambian adults: retrospective analysis of a randomised controlled trial.Identification of Helicobacter pylori infection in symptomatic patients in Surabaya, Indonesia, using five diagnostic tests.Molecular Epidemiology of Helicobacter pylori Infection in Nepal: Specific Ancestor RootHelicobacter pylori Infection in Thailand: A Nationwide Study of the CagA Phenotype.Rare Helicobacter pylori Virulence Genotypes in BhutanHelicobacter pylori virulence genes in the five largest islands of IndonesiaThe Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis: A Meta-AnalysisSeroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancerGastric adenocarcinoma in Zambia: a case-control study of HIV, lifestyle risk factors, and biomarkers of pathogenesis.Helicobacter pylori: gastric cancer and extragastric intestinal malignancies.Engineering bioinspired bacteria-adhesive clay nanoparticles with a membrane-disruptive property for the treatment of Helicobacter pylori infection.Helicobacter pylori virulence genes of minor ethnic groups in North Thailand.Noninvasive prediction of chronic atrophic gastritis in autoimmune thyroid disease in primary care.Nepalese Helicobacter pylori Genotypes Reflects a Geographical Diversity than a True Virulence FactorSystematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis.A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population.Gastric juice miR-129 as a potential biomarker for screening gastric cancer.MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives
P2860
Q28070185-51D83288-1C09-4EF2-B1BB-6BE8D28BE3A3Q28534405-06D749DA-5CBA-41F2-9B31-6C788C11855AQ33626437-64AFFF0C-CDFD-428D-A6CF-911FF4A6ABEFQ33921574-520BE07E-1CB0-43E7-904E-09DB48CA77D8Q34073186-08BA62EC-DB32-439C-86B2-E48397AF3EAFQ34721664-8A4E320B-E90C-4A81-BCF2-E69C24A20DADQ34974132-35D5BE90-A42B-48C6-97A1-E3E207B0D989Q35079534-CF01D641-53F8-4DEF-A63F-AD59A5A4585DQ35130622-B8E8C4D8-F8E6-4B29-B3B7-677507749B7CQ35208525-4DB7E952-4A99-40F5-A40F-CC3E0ECF65D3Q35726552-3B25E95A-D9A0-44F2-BAB5-2AA20A6EE494Q35769002-FB6791FA-5101-43E7-9A8A-DD038E62C426Q35941817-EE753A64-B4B5-4D4A-AEEE-68178593800EQ36125580-04676B78-CB72-44F5-AA73-7B53A624875EQ36891967-454FDDB1-DB54-4ADC-AADE-6BD21FBD05BBQ37236092-6B4630BC-55AA-4908-B736-610FCE74CF98Q37274450-58F29BC8-DA38-4CCD-A948-5DA49DFC5A40Q38041643-FA849C40-90A7-46F6-8ADE-52C24E269111Q40548402-0B56744D-851E-43C4-B557-089C9C064DDAQ42375188-3626EAF1-CCFB-4E1E-BE77-1F50520FBF90Q43533385-FDBC3817-C407-4A5E-8B2C-D917483E240FQ47715521-AEBA7240-7BD7-4DAF-8C89-8041D214F5DDQ47985401-3B564826-ECB7-4020-B733-1209F79E5628Q51316793-805DACD8-64D7-4B5E-860B-0B81EB8E1D81Q54276195-8BFD4011-A463-4B2E-BDB1-CAA52587ABD8Q57169572-5F3454A5-E961-4F77-9604-7F5F0F96D118
P2860
Serological assessment of gastric mucosal atrophy in gastric cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Serological assessment of gastric mucosal atrophy in gastric cancer.
@ast
Serological assessment of gastric mucosal atrophy in gastric cancer.
@en
Serological assessment of gastric mucosal atrophy in gastric cancer.
@nl
type
label
Serological assessment of gastric mucosal atrophy in gastric cancer.
@ast
Serological assessment of gastric mucosal atrophy in gastric cancer.
@en
Serological assessment of gastric mucosal atrophy in gastric cancer.
@nl
prefLabel
Serological assessment of gastric mucosal atrophy in gastric cancer.
@ast
Serological assessment of gastric mucosal atrophy in gastric cancer.
@en
Serological assessment of gastric mucosal atrophy in gastric cancer.
@nl
P2093
P2860
P356
P1433
P1476
Serological assessment of gastric mucosal atrophy in gastric cancer.
@en
P2093
Doerthe Kuester
Jan Bornschein
Michael Selgrad
Thomas Wex
P2860
P2888
P356
10.1186/1471-230X-12-10
P577
2012-01-31T00:00:00Z
P6179
1009170824